Publication

Marcarian HQ, Sivakoses A, Arias AM, Ihedioha OC, Lee BR, Bishop MC, Bothwell ALM. 2025. Renal cancer cells acquire immune surface protein through trogocytosis and horizontal gene transfer. Fujiwara K, editor. PLOS One. 20(5):e0325043. doi:10.1371/journal.pone.0325043.

Wallace R, Smith I, Day D, Alexander M, Weihs KL, Wiley JF. 2025 Apr. A randomized controlled trial: Evaluating whether a cognitive behavioral internet-delivered intervention targeting emotion regulation improves health-related quality of life in cancer survivors. Health Psychology. doi:10.1037/hea0001497.

Lang SM, Truong DT, Powell AJ, Kazlova V, Newburger JW, Awerbach JD, Binka E, Bradford TT, Cartoski M, Cheng A, et al. 2025 Apr. CMR Findings in the Long-Term Outcomes After Multisystem Inflammatory Syndrome in Children (MUSIC) Study. Circulation: Cardiovascular Imaging. doi:10.1161/circimaging.124.017420.

Baker FL, Stokes J, Cracchiolo MJ, Davini D, Simpson RJ, Katsanis E. 2025. Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial. Frontiers in Immunology. 16. doi:10.3389/fimmu.2025.1568862.

Pontifex T, Yang X, Tracy A, Craig Z, Zhou C. 2025. Prenatal exposure to environmentally relevant low-dosage dibutyl phthalate reduces placental efficiency in CD-1 mice. Toxicological Sciences. 206(1):86–95. doi:10.1093/toxsci/kfaf050.

Burgess JL, Beitel SC, Calkins MM, Furlong MA, Louzado Feliciano P, Kolar Gabriel J, Grant C, Goodrich JM, Graber JM, Healy O, et al. 2025. The Fire Fighter Cancer Cohort Study: Protocol for a Longitudinal Occupational Cohort Study. JMIR Research Protocols. 14:e70522. doi:10.2196/70522.

Farrera DO, Alaaldin MM, Lindberg P, Sample PA, Lenzen-Hammerel P, LaMadrid CS, Haymore R, Wright SH, Cherrington NJ. 2025. Alterations of valsartan pharmacokinetics in a rodent model of metabolic dysfunction–associated steatohepatitis. Drug Metabolism and Disposition. 53(3):100043. doi:10.1016/j.dmd.2025.100043.

Martinez-Guerrero L, Vignaux PA, Harris JS, Lane TR, Urbina F, Wright SH, Ekins S, Cherrington NJ. 2025. Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4). Molecular Pharmaceutics. 22(4):1847–1858. doi:10.1021/acs.molpharmaceut.4c00984.

Tandon V, Fistrovich A, Nogales J, Ferro F, Rokey SN, Cabel C, Miller AD, Yagel M, Duncan C, Atmasidha A, et al. 2025 Mar. Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signaling. doi:10.1101/2025.03.26.645490.

Sarami I, Hekman KE, Gupta AK, Snider JM, Ivancic D, Zec M, Kandpal M, Ben-Sahra I, Menon R, Otto EA, et al. 2025 Mar. Parallel multiOMIC analysis reveals glutamine deprivation enhances directed differentiation of renal organoids. doi:10.1101/2025.02.27.640060.

Carew JS, Espitia CM, Sureshkumar S, Carrera Espinoza MJ, Gamble ME, Wang W, Lee BR, Nawrocki ST. 2025. REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity. Cancer Letters. 613:217496. doi:10.1016/j.canlet.2025.217496.

Deressa BT, Pierz A, Jyung H, Rosario B, Andoh-B-Baidoo N, Tibebu B, Seife E, Bekele E, Hussein R, Gedif T, et al. 2025 Feb. A qualitative study on the psycho-oncological experiences of women navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia. Journal of Cancer Survivorship. doi:10.1007/s11764-024-01742-9.

Domanico MC, Collette NM, Ubick E, Ding X, Buchholz BA, Van Winkle LS. 2025. DNA adducts form in mouse lung and liver after oral naphthalene exposure. Toxicological Sciences. 205(1):42–46. doi:10.1093/toxsci/kfaf017.

Bea JW, Ochs-Balcom HM, Valencia CI, Chen Z, Blew RM, Lind KE, Caan BJ, Roe DJ, Rohan TE, Reeves KW, et al. 2025. Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence. JNCI Cancer Spectrum. 9(1). doi:10.1093/jncics/pkaf007.

Filioglou D, Leite G S F, Batatinha H, Santa-Cruz N, Davini DW, Baker FL, Simpson RJ, Katsanis E. 2025. Cytokine-induced memory-like NK cells combined with Tafasitamab demonstrate efficacy against B-cell acute lymphoblastic leukemia. Immunotherapy Advances. 5(1). doi:10.1093/immadv/ltaf025.

Galouzis N, Khawam M, Alexander EV, Yallourakis MD, Mesropyan L, Luu C, Khreiss MR, Riall TS. 2025. Decision regret and satisfaction with shared decision-making in pancreatic surgery. Journal of Gastrointestinal Surgery. 29(1):101870.

Weinfeld-Yehoudayan A, Czamanski-Cohen J, Weihs KL, Cohen M. 2025 Jan. Development and Validation of Drawing-Based Emotional Processing Scale (DRAWEP) for Art Therapists. Art Therapy.:1–16. doi:10.1080/07421656.2024.2412435.

Zinkeng A, Taylor FL, Cheong SH, Song H, Merchant JL. 2025. Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence. Cellular and Molecular Gastroenterology and Hepatology. 19(2):101425. doi:10.1016/j.jcmgh.2024.101425.

Morenz A, Liao JM. 2025 Jan. Factoring neighborhood context into readmission risk: An outstanding question for health systems and policymakers. Journal of Hospital Medicine.

Suebka S, Gin A, Su J. 2025. Frequency locked whispering evanescent resonator (FLOWER) for biochemical sensing applications. Nature Protocols. 20(6):1616–1650. doi:10.1038/s41596-024-01096-7.

Basu M, Xiao J-F, Kailasam Mani SK, Qu F, Lin Y, Duex J, Ye H, Neang V, Theodorescu D. 2025. Genes driving three-dimensional growth of immortalized cells and cancer. Cell Death & Disease. Article number: 442(16).

Harryman WL, Hinton JP, Sainz R, Gard JMC, Ryniawec JM, Rogers GC, Warfel NA, Knudsen BS, Nagle RB, Chipollini JJ, et al. 2025. Intermediate risk prostate tumors contain lethal subtypes. Frontiers in Urology. 4. doi:10.3389/fruro.2024.1487873.

Lee GJ, Hode V, Georgieva T, Rau J, Dodick DW, Schwedt TJ, Neugebauer V, Porreca F, Navratilova E. 2025. Prolactin-induced sensitization of trigeminal nociceptors promotes migraine co-morbidity in endometriosis. Cephalalgia. 45(1). doi:10.1177/03331024241313378.

Carew JS, Espitia CM, Sureshkumar S, Carrera Espinoza MJ, Gamble ME, Wang W, Lee B, Nawrocki ST. 2025. REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity. Cancer Letters. 613.

Zhao Y, Zhou C, Zhang S, Mishra JS, Li H, Lei W, Wang K, Kumar S, Zheng J. 2024. An endogenous aryl hydrocarbon receptor ligand induces preeclampsia‐like phenotypes in rats. The Journal of Physiology. 603(2):579–594. doi:10.1113/jp287503.